Your browser doesn't support javascript.
loading
CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimen.
Thibault, Gilles; Paintaud, Gilles; Legendre, Christophe; Merville, Pierre; Coulon, Maxime; Chasseuil, Elodie; Ternant, David; Rostaing, Lionel; Durrbach, Antoine; Di Giambattista, Fabienne; Büchler, Matthias; Lebranchu, Yvon.
Afiliação
  • Thibault G; Laboratoire d'Immunologie, Bretonneau Hospital, CHRU de Tours, CNRS, GICC UMR 7292, Université François-Rabelais de Tours, Tours, France.
  • Paintaud G; Laboratoire de Pharmacologie-Toxicologie, Bretonneau Hospital, CHRU de Tours, CNRS, GICC UMR 7292, Université François-Rabelais de Tours, Tours, France.
  • Legendre C; Service de Nephrologie-Transplantation, Hôpital Necker, Assistance Publique-Hôpitaux de Paris, Université Paris Descartes, INSERM U 845, Paris, France.
  • Merville P; Department of Nephrology, Transplantation and Dialysis, CHU Bordeaux, Pellegrin Hospital, UMR-CNRS 5164, Bordeaux University, Bordeaux, France.
  • Coulon M; Laboratoire d'Immunologie, Bretonneau Hospital, CHRU de Tours, CNRS, GICC UMR 7292, Université François-Rabelais de Tours, Tours, France.
  • Chasseuil E; Laboratoire de Pharmacologie-Toxicologie, Bretonneau Hospital, CHRU de Tours, CNRS, GICC UMR 7292, Université François-Rabelais de Tours, Tours, France.
  • Ternant D; Laboratoire de Pharmacologie-Toxicologie, Bretonneau Hospital, CHRU de Tours, CNRS, GICC UMR 7292, Université François-Rabelais de Tours, Tours, France.
  • Rostaing L; Department of Nephrology, Dialysis and Organ Transplantation, Rangueil Hospital, Toulouse, France.
  • Durrbach A; Department of Nephrology, INSERM UMR 1197, Kremlin Bicetre Hospital, Le Kremlin-Bicêtre, France.
  • Di Giambattista F; Novartis Pharma SAS, Rueil-Malmaison, France.
  • Büchler M; Department of Nephrology and Clinical Immunology, Bretonneau Hospital, CHRU de Tours, EA4245, Université François-Rabelais de Tours, Tours, France.
  • Lebranchu Y; Department of Nephrology and Clinical Immunology, Bretonneau Hospital, CHRU de Tours, EA4245, Université François-Rabelais de Tours, Tours, France.
Transpl Int ; 29(2): 184-95, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26369526
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Transplante de Rim / Ciclosporina / Anticorpos Bloqueadores / Subunidade alfa de Receptor de Interleucina-2 / Imunossupressores / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Transplante de Rim / Ciclosporina / Anticorpos Bloqueadores / Subunidade alfa de Receptor de Interleucina-2 / Imunossupressores / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article